Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Reagent
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Biology== In the field of biology, the [[biotechnology]] revolution in the 1980s grew from the development of reagents that could be used to identify and manipulate the chemical matter in and on cells.<ref>{{cite journal|last1=Fox|first1=Jeffrey L|title=Antibody reagents revolutionizing immunology|journal=Chemical & Engineering News Archive|date=1 January 1979|volume=57 |pages=15β17|doi=10.1021/cen-v057n001.p015}}</ref><ref name=NIHreport1998>{{cite web |title=Report of the National Institutes of Health (NIH) Working Group on Research Tools|url=http://www.nih.gov/news/researchtools/index.htm|publisher=NIH|archive-url=https://web.archive.org/web/20000816014021/http://www.nih.gov/news/researchtools/index.htm |archive-date=August 16, 2000|date=June 4, 1998}}</ref> These reagents included [[Antibody#Research applications|antibodies]] ([[Polyclonal antibodies|polyclonal]] and [[Monoclonal antibody|monoclonal]]), [[oligomers]], all sorts of [[model organisms]] and [[immortalised cell line]]s, reagents and methods for [[molecular cloning]] and [[DNA replication]], and many others.<ref name=NIHreport1998/><ref>{{cite journal |last1=Ishino |first1=S|last2=Ishino|first2=Y|title=DNA polymerases as useful reagents for biotechnology: the history of developmental research in the field |journal=Frontiers in Microbiology|date=29 August 2014|volume=5|pages=465|pmid=25221550|pmc=4148896|doi=10.3389/fmicb.2014.00465|doi-access=free}}</ref> <!-- "Tool compound" redirects to this heading --> ===Tool compounds=== Tool compounds are an important class of reagent in biology. They are small molecules or biochemicals like [[siRNA]] or antibodies that are known to affect a given biomolecule{{ambiguous|reason=needs punctuating to clarify phrase structure|date=February 2024}}βfor example a [[drug target]]βbut are unlikely to be useful as drugs themselves, and are often starting points in the [[drug discovery]] process.<ref>{{cite journal |last1=Kenakin|first1=T|last2=Bylund|first2=DB|last3=Toews|first3=ML|last4=Mullane|first4=K|last5=Winquist|first5=RJ|last6=Williams|first6=M|title=Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st century |journal=Biochemical Pharmacology|date=1 January 2014 |volume=87 |issue=1 |pages=64β77 |doi=10.1016/j.bcp.2013.10.024|pmid=24269285}}</ref><ref>{{cite journal|last1=Lindsley|first1=CW|title=2013 Philip S. Portoghese Medicinal Chemistry Lectureship: drug discovery targeting allosteric sites|journal=Journal of Medicinal Chemistry|date=25 September 2014 |volume=57 |issue=18 |pages=7485β7498|pmid=25180768|pmc=4174999|doi=10.1021/jm5011786}}</ref> However, many natural substances are hits in almost any assay in which they are tested, and therefore not useful as tool compounds. Medicinal chemists class them instead as [[pan-assay interference compounds]]. One example is [[curcumin]].<ref>{{cite journal|last1=Baker|first1=Monya|title=Deceptive curcumin offers cautionary tale for chemists |journal=Nature |date=9 January 2017|volume=541|issue=7636|pages=144β145|doi=10.1038/541144a|pmid=28079090|bibcode=2017Natur.541..144B|doi-access=free}}</ref><ref>{{cite journal|last1=Dahlin|first1=JL|last2=Walters|first2=MA|title=The essential roles of chemistry in high-throughput screening triage |journal=[[Future Medicinal Chemistry]]|date=July 2014|volume=6|issue=11|pages=1265β1290|pmid=25163000|pmc=4465542|doi=10.4155/fmc.14.60}}</ref><ref>{{cite journal|last1=Baell|first1=JB|last2=Holloway|first2=GA|title=New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.|journal=Journal of Medicinal Chemistry |date=8 April 2010|volume=53|issue=7|pages=2719β2740|doi=10.1021/jm901137j|pmid=20131845|citeseerx=10.1.1.394.9155}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)